In vitro experiments showed that MT1M upregulation significantly inhibited colony formation, proliferation, migration, and invasion of thyroid cancer (PTC) cell lines, it is suggested that MT1M may be a potential new marker and target for thyroid cancer therapy [32]. This evidence concerns the gene MT1M and thyroid gland carcinoma.